PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"34379922","Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women","Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B; HPTN 083 Study Team.","N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016.","Landovitz RJ","N Engl J Med","2021","2021/08/11","PMC8448593","NIHMS1735236","10.1056/NEJMoa2101016"
"37018493","Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections","Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C; DoxyPEP Study Team.","N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934.","Luetkemeyer AF","N Engl J Med","2023","2023/04/05","PMC10140182","NIHMS1889907","10.1056/NEJMoa2211934"
"35693874","Efficacy of single-dose HPV vaccination among young African women","Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Pinder LF, Donnell D, Wakhungu I, Congo O, Biwott C, Kimanthi S, Oluoch L, Heller KB, Leingang H, Morrison S, Rechkina E, Cherne S, Schaafsma TT, McClelland RS, Celum C, Baeten JM, Mugo N.","NEJM Evid. 2022 Jun;1(5):EVIDoa2100056. doi: 10.1056/EVIDoa2100056. Epub 2022 Apr 11.","Barnabas RV","NEJM Evid","2022","2022/06/13","PMC9172784","","10.1056/EVIDoa2100056"
"27424812","Antiretroviral Therapy for the Prevention of HIV-1 Transmission","Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR; HPTN 052 Study Team.","N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.","Cohen MS","N Engl J Med","2016","2016/07/19","PMC5049503","NIHMS817172","10.1056/NEJMoa1600693"
"22784037","Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team.","N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.","Baeten JM","N Engl J Med","2012","2012/07/13","PMC3770474","NIHMS493581","10.1056/NEJMoa1108524"
"21767103","Prevention of HIV-1 infection with early antiretroviral therapy","Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.","N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.","Cohen MS","N Engl J Med","2011","2011/07/20","PMC3200068","NIHMS320818","10.1056/NEJMoa1105243"
"33090877","Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials","Mehrotra DV, Janes HE, Fleming TR, Annunziato PW, Neuzil KM, Carpp LN, Benkeser D, Brown ER, Carone M, Cho I, Donnell D, Fay MP, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Juraska M, Luedtke A, Nason M, Vandebosch A, Zhou H, Cohen MS, Corey L, Hartzel J, Follmann D, Gilbert PB.","Ann Intern Med. 2021 Feb;174(2):221-228. doi: 10.7326/M20-6169. Epub 2020 Oct 22.","Mehrotra DV","Ann Intern Med","2021","2020/10/22","PMC7596738","","10.7326/M20-6169"
"33740057","Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083","Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, McCauley M, Cummings V, Ahmed S, Haines CD, Bushman LR, Petropoulos C, Persaud D, Adeyeye A, Kofron R, Rinehart A, St Clair M, Rooney JF, Pryluka D, Coelho L, Gaur A, Middelkoop K, Phanuphak N, Cohen MS, Hendrix CW, Anderson P, Hanscom B, Donnell D, Landovitz RJ, Eshleman SH.","J Infect Dis. 2021 Nov 16;224(9):1581-1592. doi: 10.1093/infdis/jiab152.","Marzinke MA","J Infect Dis","2021","2021/03/19","PMC8599849","","10.1093/infdis/jiab152"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"34579786","Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial","Barnabas RV, Brown ER, Onono M, Bukusi EA, Njoroge B, Winer RL, Donnell D, Galloway D, Cherne S, Heller K, Leingang H, Morrison S, Rechkina E, McClelland RS, Baeten JM, Celum C, Mugo N; KEN SHE Study Team.","Trials. 2021 Sep 27;22(1):661. doi: 10.1186/s13063-021-05608-8.","Barnabas RV","Trials","2021","2021/09/28","PMC8475401","","10.1186/s13063-021-05608-8"
"30715403","Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents","Cohen MS, Donnell D.","J Infect Dis. 2020 Jan 2;221(2):172-174. doi: 10.1093/infdis/jiz041.","Cohen MS","J Infect Dis","2020","2019/02/05","PMC6936000","","10.1093/infdis/jiz041"
"30293490","Adaptive non-inferiority margins under observable non-constancy","Hanscom B, Hughes JP, Williamson BD, Donnell D.","Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3318-3332. doi: 10.1177/0962280218801134. Epub 2018 Oct 8.","Hanscom B","Stat Methods Med Res","2019","2018/10/09","PMC8128326","NIHMS1042638","10.1177/0962280218801134"
"29039265","HIV prevention trial design in an era of effective pre-exposure prophylaxis","Cutrell A, Donnell D, Dunn DT, Glidden DV, Grobler A, Hanscom B, Stancil BS, Meyer RD, Wang R, Cuffe RL.","HIV Clin Trials. 2017 Nov-Dec;18(5-6):177-188. doi: 10.1080/15284336.2017.1379676. Epub 2017 Oct 17.","Cutrell A","HIV Clin Trials","2017","2017/10/18","PMC6084772","EMS78899","10.1080/15284336.2017.1379676"
"31221591","Ethical considerations for new HIV prevention trials","Sugarman J, Celum CL, Donnell D, Mayer KH.","Lancet HIV. 2019 Aug;6(8):e489-e491. doi: 10.1016/S2352-3018(19)30184-5. Epub 2019 Jun 17.","Sugarman J","Lancet HIV","2019","2019/06/22","","","10.1016/S2352-3018(19)30184-5"
"33527128","Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection","Stalter RM, Baeten JM, Donnell D, Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Mugo N, Mujugira A, Marzinke M, Hendrix C, Gandhi M; Partners PrEP Study Team.","Clin Infect Dis. 2021 Feb 1;72(3):486-489. doi: 10.1093/cid/ciaa785.","Stalter RM","Clin Infect Dis","2021","2021/02/02","PMC7850546","","10.1093/cid/ciaa785"
"36746170","Addressing the evidence gap for HIV prevention in pregnancy","Donnell D.","Lancet HIV. 2023 Mar;10(3):e144-e145. doi: 10.1016/S2352-3018(23)00025-5. Epub 2023 Feb 3.","Donnell D","Lancet HIV","2023","2023/02/06","","","10.1016/S2352-3018(23)00025-5"
"34454678","Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial","Sugarman J, Donnell DJ, Hanscom B, McCauley M, Grinsztejn B, Landovitz RJ.","Lancet HIV. 2021 Nov;8(11):e723-e728. doi: 10.1016/S2352-3018(21)00153-3. Epub 2021 Aug 26.","Sugarman J","Lancet HIV","2021","2021/08/29","","","10.1016/S2352-3018(21)00153-3"
"37392020","Perspectives on Design Approaches for HIV Prevention Efficacy Trials","Prudden HJ, Tatoud R, Janes H, Wallace S, Miller V, Bekker LG, Donnell D.","AIDS Res Hum Retroviruses. 2023 Jun 30. doi: 10.1089/AID.2022.0150. Online ahead of print.","Prudden HJ","AIDS Res Hum Retroviruses","2023","2023/07/01","","","10.1089/AID.2022.0150"
"31078451","Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials","Janes H, Donnell D, Gilbert PB, Brown ER, Nason M.","Lancet HIV. 2019 Jul;6(7):e475-e482. doi: 10.1016/S2352-3018(19)30133-X. Epub 2019 May 8.","Janes H","Lancet HIV","2019","2019/05/13","PMC6612578","NIHMS1529465","10.1016/S2352-3018(19)30133-X"
"36550769","Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project","Parkin N, Gao F, Grebe E, Cutrell A, Das M, Donnell D, Duerr A, Glidden DV, Hughes JP, Murray J, Robertson MN, Zinserling J, Lau J, Miller V; Forum for Collaborative Research Recency Assay Working Group.","Clin Pharmacol Ther. 2023 Jul;114(1):29-40. doi: 10.1002/cpt.2830. Epub 2023 Jan 5.","Parkin N","Clin Pharmacol Ther","2023","2022/12/23","","","10.1002/cpt.2830"
"33710023","Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis","Nickolas TL, Barasch J, Mugwanya KK, Branch AD, Heffron R, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, Wyatt CM; Partners PrEP Study Team.","AIDS. 2021 Jun 1;35(7):1147-1149. doi: 10.1097/QAD.0000000000002865.","Nickolas TL","AIDS","2021","2021/03/12","PMC8102362","NIHMS1691885","10.1097/QAD.0000000000002865"
"34910143","Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial","Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.","Clin Infect Dis. 2022 Sep 10;75(4):586-595. doi: 10.1093/cid/ciab1027.","Mugo NR","Clin Infect Dis","2022","2021/12/15","PMC9464069","","10.1093/cid/ciab1027"
"36332654","Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study","Probert WJM, Sauter R, Pickles M, Cori A, Bell-Mandla NF, Bwalya J, Abeler-Dörner L, Bock P, Donnell DJ, Floyd S, Macleod D, Piwowar-Manning E, Skalland T, Shanaube K, Wilson E, Yang B, Ayles H, Fidler S, Hayes RJ, Fraser C; HPTN 071 (PopART) Study Team.","Lancet HIV. 2022 Nov;9(11):e771-e780. doi: 10.1016/S2352-3018(22)00259-4.","Probert WJM","Lancet HIV","2022","2022/11/04","PMC9646978","","10.1016/S2352-3018(22)00259-4"
"27699594","Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception","Heffron R, Parikh UM, Penrose KJ, Mugo N, Donnell D, Celum C, Mellors JW, Baeten JM; Partners PrEP Study Team.","AIDS Behav. 2017 Jul;21(7):2173-2179. doi: 10.1007/s10461-016-1563-y.","Heffron R","AIDS Behav","2017","2016/10/05","PMC5378697","NIHMS820756","10.1007/s10461-016-1563-y"
"35393864","Practical issues in operationalizing the design and outcome evaluation of cluster randomized trials","Donnell D.","Clin Trials. 2022 Aug;19(4):407-415. doi: 10.1177/17407745221087465. Epub 2022 Apr 8.","Donnell D","Clin Trials","2022","2022/04/08","PMC9378425","NIHMS1784758","10.1177/17407745221087465"
"35579012","Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women","Giovenco D, Pettifor A, Powers KA, Hightow-Weidman L, Pence BW, Celum C, Delany-Moretlwe S, Hosek S, Donnell D, Anderson PL, Mgodi N, Bekker LG.","AIDS. 2022 Jul 1;36(8):1151-1159. doi: 10.1097/QAD.0000000000003216. Epub 2022 May 16.","Giovenco D","AIDS","2022","2022/05/17","PMC9486991","NIHMS1785370","10.1097/QAD.0000000000003216"
"34911750","Association between rectal gonorrhoea and HIV incidence in men who have sex with men: a meta-analysis","Donnell D, Zewdie K, Ratna N, Miller V, Saunders JM, Gill ON, Delpech V, Mohammed H.","Sex Transm Infect. 2022 Nov;98(7):492-496. doi: 10.1136/sextrans-2021-055254. Epub 2021 Dec 15.","Donnell D","Sex Transm Infect","2022","2021/12/16","PMC9613867","","10.1136/sextrans-2021-055254"
"23764641","Cross-sectional HIV incidence estimation in HIV prevention research","Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH.","J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S233-9. doi: 10.1097/QAI.0b013e3182986fdf.","Brookmeyer R","J Acquir Immune Defic Syndr","2013","2013/06/15","PMC3737594","NIHMS485409","10.1097/QAI.0b013e3182986fdf"
"33777327","Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions","Fleming TR, DeGruttola V, Donnell D.","Stat Commun Infect Dis. 2019;11(1):20190001. doi: 10.1515/scid-2019-0001. Epub 2019 Jul 18.","Fleming TR","Stat Commun Infect Dis","2019","2021/03/29","PMC7996711","NIHMS1059771","10.1515/scid-2019-0001"
"35775502","HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)","Fogel JM, Wilson EA, Piwowar-Manning E, Breaud A, Clarke W, Petropoulos C, Moore A, Fraser C, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D, Eshleman SH; HPTN 071 (PopART) Study Team.","J Int AIDS Soc. 2022 Jul;25(7):e25941. doi: 10.1002/jia2.25941.","Fogel JM","J Int AIDS Soc","2022","2022/07/01","PMC9248006","","10.1002/jia2.25941"
"36053045","Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial","Hanscom BS, Donnell DJ, Fleming TR, Hughes JP, McCauley M, Grinsztejn B, Landovitz RJ, Emerson SS.","Clin Trials. 2022 Dec;19(6):605-612. doi: 10.1177/17407745221118371. Epub 2022 Sep 2.","Hanscom BS","Clin Trials","2022","2022/09/02","PMC9691580","NIHMS1825497","10.1177/17407745221118371"
"36524872","Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052","Zangeneh SZ, Wilson EA, Ahluwalia S, Donnell DJ, Chen YQ, Grinsztejn B, Melo MG, Godbole SV, Hosseinipour MC, Taha T, Kumwenda J, McCauley M, Cohen MS, Nielsen-Saines K.","AIDS Care. 2023 Jun;35(6):824-832. doi: 10.1080/09540121.2022.2141187. Epub 2022 Dec 16.","Zangeneh SZ","AIDS Care","2023","2022/12/16","PMC10191867","NIHMS1846320","10.1080/09540121.2022.2141187"
"34195685","CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions","Richert-Spuhler LE, Mar CM, Shinde P, Wu F, Hong T, Greene E, Hou S, Thomas K, Gottardo R, Mugo N, de Bruyn G, Celum C, Baeten JM, Lingappa JR, Lund JM; Partners in Prevention HSV/HIV Transmission Study; and the Partners PrEP Study Teams.","Cell Rep Med. 2021 Jun 15;2(6):100322. doi: 10.1016/j.xcrm.2021.100322. eCollection 2021 Jun 15.","Richert-Spuhler LE","Cell Rep Med","2021","2021/07/01","PMC8233694","","10.1016/j.xcrm.2021.100322"
"24384592","Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial","Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, Baeten JM; Partners PrEP Study Team.","AIDS. 2013 Aug 24;27(13):2155-60. doi: 10.1097/QAD.0b013e3283629037.","Murnane PM","AIDS","2013","2014/01/04","PMC3882910","NIHMS505879","10.1097/QAD.0b013e3283629037"
"34849635","How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?","Mitchell KM, Maheu-Giroux M, Dimitrov D, Moore M, Hughes JP, Donnell D, Beyrer C, El-Sadr WM, Cohen MS, Boily MC.","Clin Infect Dis. 2022 Aug 24;75(1):163-169. doi: 10.1093/cid/ciab976.","Mitchell KM","Clin Infect Dis","2022","2021/12/01","PMC9403299","","10.1093/cid/ciab976"
"36447611","Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)","Fogel JM, Zewdie K, Clarke WA, Piwowar-Manning E, Breaud A, Moore A, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D, Eshleman SH; HPTN 071 (PopART) Study Team.","Open Forum Infect Dis. 2022 Oct 31;9(11):ofac576. doi: 10.1093/ofid/ofac576. eCollection 2022 Nov.","Fogel JM","Open Forum Infect Dis","2022","2022/11/30","PMC9697607","","10.1093/ofid/ofac576"
"24785951","Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception","Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C, Baeten JM; Partners PrEP Study Team.","AIDS. 2014 Jul 31;28(12):1825-30. doi: 10.1097/QAD.0000000000000290.","Murnane PM","AIDS","2014","2014/05/03","PMC4136509","NIHMS612033","10.1097/QAD.0000000000000290"
"25493602","Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception","Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM; Partners PrEP Study Team.","AIDS. 2014 Nov 28;28(18):2771-6. doi: 10.1097/QAD.0000000000000493.","Heffron R","AIDS","2014","2014/12/11","PMC4266161","NIHMS635151","10.1097/QAD.0000000000000493"
"31660332","Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults","Nickolas TL, Yin MT, Hong T, Mugwanya KK, Branch AD, Heffron R, Ramalho J, Nandakumar R, Dworakowski E, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, Wyatt CM; Partners PrEP Study Team.","Open Forum Infect Dis. 2019 Jul 28;6(10):ofz338. doi: 10.1093/ofid/ofz338. eCollection 2019 Oct.","Nickolas TL","Open Forum Infect Dis","2019","2019/10/30","PMC6778426","","10.1093/ofid/ofz338"
"25038355","Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial","Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM; Partners PrEP Study Team.","JAMA. 2014 Jul 23-30;312(4):362-71. doi: 10.1001/jama.2014.8735.","Mugo NR","JAMA","2014","2014/07/20","PMC4362516","NIHMS666490","10.1001/jama.2014.8735"
"27029778","Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women","Mugwanya K, Baeten J, Celum C, Donnell D, Nickolas T, Mugo N, Branch A, Tappero J, Kiarie J, Ronald A, Yin M, Wyatt C; Partners PrEP Study Team.","J Infect Dis. 2016 Oct 1;214(7):1050-7. doi: 10.1093/infdis/jiw125. Epub 2016 Mar 29.","Mugwanya K","J Infect Dis","2016","2016/04/01","PMC5021224","","10.1093/infdis/jiw125"
"25756285","HIV treatment-as-prevention research: taking the right road at the crossroads","Hayes R, Fidler S, Cori A, Fraser C, Floyd S, Ayles H, Beyers N, El-Sadr W; HPTN 071 (PopART) Study Team.","PLoS Med. 2015 Mar 10;12(3):e1001800. doi: 10.1371/journal.pmed.1001800. eCollection 2015 Mar.","Hayes R","PLoS Med","2015","2015/03/11","PMC4355412","","10.1371/journal.pmed.1001800"
"36711739","ADAPTIVE TIME LOCATION SAMPLING FOR COMPASS, A SARS-COV-2 PREVALENCE STUDY IN FIFTEEN DIVERSE COMMUNITIES IN THE UNITED STATES","Zangeneh SZ, Skalland T, Yuhas K, Emel L, De Dieu Tapsoba J, Reed D, Amos CI, Donnell D, Moore A, Justman J; CoVPN 5002 Study Team.","medRxiv. 2023 Jan 11:2023.01.10.23284400. doi: 10.1101/2023.01.10.23284400. Preprint.","Zangeneh SZ","medRxiv","2023","2023/01/30","PMC9882424","","10.1101/2023.01.10.23284400"
"27863998","Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study","Justman J, Reed JB, Bicego G, Donnell D, Li K, Bock N, Koler A, Philip NM, Mlambo CK, Parekh BS, Duong YT, Ellenberger DL, El-Sadr WM, Nkambule R.","Lancet HIV. 2017 Feb;4(2):e83-e92. doi: 10.1016/S2352-3018(16)30190-4. Epub 2016 Nov 16.","Justman J","Lancet HIV","2017","2016/11/20","PMC5291824","NIHMS835272","10.1016/S2352-3018(16)30190-4"
"27053765","Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy","Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, Baeten JM; Partners PrEP Study Team.","J Infect Dis. 2016 Jul 15;214(2):212-5. doi: 10.1093/infdis/jiw131. Epub 2016 Apr 6.","Mujugira A","J Infect Dis","2016","2016/04/08","PMC4918825","","10.1093/infdis/jiw131"
"26731753","Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation","Weis JF, Baeten JM, McCoy CO, Warth C, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Mugo N, Matsen FA IV, Celum C, Lehman DA; Partners PrEP Study Team.","AIDS. 2016 Jan 2;30(1):31-5. doi: 10.1097/QAD.0000000000000915.","Weis JF","AIDS","2016","2016/01/06","PMC4704103","NIHMS728615","10.1097/QAD.0000000000000915"
"35657948","High HIV incidence among young women in South Africa: Data from a large prospective study","Palanee-Phillips T, Rees HV, Heller KB, Ahmed K, Batting J, Beesham I, Heffron R, Justman J, Makkan H, Mastro TD, Morrison SA, Mugo N, Nair G, Kiarie J, Philip NM, Pleaner M, Reddy K, Selepe P, Steyn PS, Scoville CW, Smit J, Thomas KK, Donnell D, Baeten JM; ECHO Trial Consortium.","PLoS One. 2022 Jun 3;17(6):e0269317. doi: 10.1371/journal.pone.0269317. eCollection 2022.","Palanee-Phillips T","PLoS One","2022","2022/06/03","PMC9165791","","10.1371/journal.pone.0269317"
"24143205","Recent patterns in population-based HIV prevalence in Swaziland","Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, Duong YT, Patel H, Bock N, Philip N, Mao C, Justman J.","PLoS One. 2013 Oct 15;8(10):e77101. doi: 10.1371/journal.pone.0077101. eCollection 2013.","Bicego GT","PLoS One","2013","2013/10/22","PMC3797108","","10.1371/journal.pone.0077101"
"28692542","The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion","Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, Lingappa JR, Ronald A, Fife K, Coombs RW; Partners PrEP Study Team.","AIDS. 2017 Sep 10;31(14):2007-2016. doi: 10.1097/QAD.0000000000001577.","Donnell D","AIDS","2017","2017/07/11","PMC5578893","NIHMS892026","10.1097/QAD.0000000000001577"
"29424774","In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?","Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC.","AIDS. 2018 Mar 27;32(6):809-818. doi: 10.1097/QAD.0000000000001766.","Mitchell KM","AIDS","2018","2018/02/10","PMC5854532","NIHMS939289","10.1097/QAD.0000000000001766"
"35818869","The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa","Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D, Wilson E, Piwowar-Manning E, Agyei Y, Bell-Mandla NF, Dunbar R, Schaap A, Macleod D, Floyd S, Bock P, Fidler S, Seeley J, Stangl A, Bond V, Ayles H, Hayes RJ; HPTN 071 (PopART) study team.","J Int AIDS Soc. 2022 Jul;25 Suppl 1(Suppl 1):e25931. doi: 10.1002/jia2.25931.","Hargreaves JR","J Int AIDS Soc","2022","2022/07/12","PMC9274206","","10.1002/jia2.25931"
"30711064","The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study","Adamson B, El-Sadr W, Dimitrov D, Gamble T, Beauchamp G, Carlson JJ, Garrison L Jr, Donnell D.","Value Health. 2019 Feb;22(2):194-202. doi: 10.1016/j.jval.2018.09.001. Epub 2018 Nov 2.","Adamson B","Value Health","2019","2019/02/04","PMC6362462","NIHMS1511500","10.1016/j.jval.2018.09.001"
"33136735","Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America","Moore M, Boily MC, Mitchell KM, Donnell DD, Cohen MS, Dimitrov DT.","J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):395-398. doi: 10.1097/QAI.0000000000002477.","Moore M","J Acquir Immune Defic Syndr","2020","2020/11/02","","","10.1097/QAI.0000000000002477"
"25587020","Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis","Lehman DA, Baeten JM, McCoy CO, Weis JF, Peterson D, Mbara G, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Frenkel L, Ndase P, Mugo NR, Celum C, Overbaugh J, Matsen FA; Partners PrEP Study Team.","J Infect Dis. 2015 Apr 15;211(8):1211-8. doi: 10.1093/infdis/jiu677. Epub 2015 Jan 13.","Lehman DA","J Infect Dis","2015","2015/01/15","PMC4402339","","10.1093/infdis/jiu677"
"28732773","Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study","Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks DN, Baeten JM; Partners PrEP Study Team.","Lancet HIV. 2017 Oct;4(10):e449-e456. doi: 10.1016/S2352-3018(17)30110-8. Epub 2017 Jul 18.","Heffron R","Lancet HIV","2017","2017/07/23","PMC5649365","NIHMS910579","10.1016/S2352-3018(17)30110-8"
"35880999","Sample size calculation for active-arm trial with counterfactual incidence based on recency assay","Gao F, Glidden DV, Hughes JP, Donnell DJ.","Stat Commun Infect Dis. 2021 Nov 10;13(1):20200009. doi: 10.1515/scid-2020-0009. eCollection 2021 Jan 1.","Gao F","Stat Commun Infect Dis","2021","2022/07/26","PMC8865397","","10.1515/scid-2020-0009"
"28634661","Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda","Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R; Partners Demonstration Project Team.","AIDS Behav. 2017 Aug;21(8):2509-2518. doi: 10.1007/s10461-017-1829-z.","Velloza J","AIDS Behav","2017","2017/06/22","PMC5552192","NIHMS886597","10.1007/s10461-017-1829-z"
"21998703","Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention","Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Panteleeff D, Krows M, Shah H, Revall J, Morrison S, Ondrejcek L, Ingram C, Coombs RW, Lingappa JR, Celum C; Partners PrEP Study Team.","PLoS One. 2011;6(10):e25828. doi: 10.1371/journal.pone.0025828. Epub 2011 Oct 5.","Mujugira A","PLoS One","2011","2011/10/15","PMC3187805","","10.1371/journal.pone.0025828"
"23815575","Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals","Pattacini L, Murnane PM, Kahle EM, Bolton MJ, Delrow JJ, Lingappa JR, Katabira E, Donnell D, McElrath MJ, Baeten JM, Lund JM.","AIDS Res Hum Retroviruses. 2013 Oct;29(10):1321-9. doi: 10.1089/AID.2013.0075. Epub 2013 Jul 30.","Pattacini L","AIDS Res Hum Retroviruses","2013","2013/07/03","PMC3785803","","10.1089/AID.2013.0075"
"24321986","Supporting research sites in resource-limited settings: challenges in implementing information technology infrastructure","Whalen CJ, Donnell D, Tartakovsky M.","J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1(0 1):S44-9. doi: 10.1097/QAI.0000000000000039.","Whalen CJ","J Acquir Immune Defic Syndr","2014","2013/12/11","PMC4195443","NIHMS542866","10.1097/QAI.0000000000000039"
"25885664","Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions","Ndase P, Celum C, Kidoguchi L, Ronald A, Fife KH, Bukusi E, Donnell D, Baeten JM; Partners PrEP Study Team.","PLoS One. 2015 Apr 17;10(4):e0123005. doi: 10.1371/journal.pone.0123005. eCollection 2015.","Ndase P","PLoS One","2015","2015/04/18","PMC4401675","","10.1371/journal.pone.0123005"
"34919554","Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)","Grant-McAuley W, Klock E, Laeyendecker O, Piwowar-Manning E, Wilson E, Clarke W, Breaud A, Moore A, Ayles H, Kosloff B, Shanaube K, Bock P, Mandla N, van Deventer A, Fidler S, Donnell D, Hayes R, Eshleman SH; HPTN 071 (PopART) Study Team.","PLoS One. 2021 Dec 17;16(12):e0258644. doi: 10.1371/journal.pone.0258644. eCollection 2021.","Grant-McAuley W","PLoS One","2021","2021/12/17","PMC8682874","","10.1371/journal.pone.0258644"
"25531343","Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial","Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM; Partners PrEP Study Team.","JAMA Intern Med. 2015 Feb;175(2):246-54. doi: 10.1001/jamainternmed.2014.6786.","Mugwanya KK","JAMA Intern Med","2015","2014/12/23","PMC4354899","NIHMS665731","10.1001/jamainternmed.2014.6786"
"24442233","Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study","Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, De Bruyn G, Wald A, Donnell D, John-Stewart G, Delany-Moretlwe S, Mugo NR, Farquhar C, Lingappa JR; Partners in Prevention HSVHIV Transmission Study Team.","J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e90-4. doi: 10.1097/QAI.0b013e3182a2db02.","Kahle EM","J Acquir Immune Defic Syndr","2014","2014/01/21","PMC3898592","NIHMS501323","10.1097/QAI.0b013e3182a2db02"
"31654322","Making Breast Screening Convenient: a Community-Based Breast Screening Event During a Historically Black University's Homecoming Festivities","Williams MS, Young C, McKinney S, Simon Hawkins OS, Roberson C, Udemgba C, Rogers DB, Wells J, Lake DA, Davis D, Young T, Donnell D, Herring BJ.","J Cancer Educ. 2020 Aug;35(4):832-835. doi: 10.1007/s13187-019-01600-8.","Williams MS","J Cancer Educ","2020","2019/10/27","","","10.1007/s13187-019-01600-8"
"25259704","Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men","Were EO, Heffron R, Mugo NR, Celum C, Mujugira A, Bukusi EA, Baeten JM; Partners PrEP Study Team.","AIDS. 2014 Aug 24;28(13):1977-82. doi: 10.1097/QAD.0000000000000313.","Were EO","AIDS","2014","2014/09/27","PMC4216472","NIHMS637333","10.1097/QAD.0000000000000313"
"35417485","Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial","Velloza J, Poovan N, Ndlovu N, Khoza N, Morton JF, Omony J, Mkwanazi E, Grabow C, Donnell D, Munthali R, Baeten JM, Hosek S, Celum C, Delany-Moretlwe S.","PLoS One. 2022 Apr 13;17(4):e0266665. doi: 10.1371/journal.pone.0266665. eCollection 2022.","Velloza J","PLoS One","2022","2022/04/13","PMC9007385","","10.1371/journal.pone.0266665"
"32658130","Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda","Stalter R, Mugwanya K, Thomas K, Donnell D, Mujugira A, Ngure K, Celum C, Kidoguchi L, Bukusi E, Baeten J, Heffron R; Partners Demonstration Project Team.","J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):174-181. doi: 10.1097/QAI.0000000000002434.","Stalter R","J Acquir Immune Defic Syndr","2020","2020/07/14","PMC7495981","","10.1097/QAI.0000000000002434"
"26487343","Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention","Murnane PM, Brown ER, Donnell D, Coley RY, Mugo N, Mujugira A, Celum C, Baeten JM; Partners PrEP Study Team.","Am J Epidemiol. 2015 Nov 15;182(10):848-56. doi: 10.1093/aje/kwv202. Epub 2015 Oct 19.","Murnane PM","Am J Epidemiol","2015","2015/10/22","PMC4634306","","10.1093/aje/kwv202"
"35822945","PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project","Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM; POWER Study Team.","J Int AIDS Soc. 2022 Jul;25(7):e25962. doi: 10.1002/jia2.25962.","Celum CL","J Int AIDS Soc","2022","2022/07/13","PMC9278271","","10.1002/jia2.25962"
"29894385","Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis","Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM; Partners Demonstration Study Team.","AIDS. 2018 Aug 24;32(13):1891-1898. doi: 10.1097/QAD.0000000000001922.","Pyra M","AIDS","2018","2018/06/13","PMC6061961","NIHMS980328","10.1097/QAD.0000000000001922"
"36618897","Estimating benefits of using on-demand oral prep by MSM: A comparative modeling study of the US and Thailand","Stansfield SE, Moore M, Boily MC, Hughes JP, Donnell DJ, Dimitrov DT.","EClinicalMedicine. 2022 Dec 26;56:101776. doi: 10.1016/j.eclinm.2022.101776. eCollection 2023 Feb.","Stansfield SE","EClinicalMedicine","2022","2023/01/09","PMC9813675","","10.1016/j.eclinm.2022.101776"
"24979446","Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial","Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM; Partners PrEP Study Team.","Ann Intern Med. 2014 Jul 1;161(1):11-9. doi: 10.7326/M13-2471.","Celum C","Ann Intern Med","2014","2014/07/01","","","10.7326/M13-2471"
"32976203","Brief Report: Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation","Wanga V, Mackelprang RD, Thomas KK, Donnell D, Cohen CR, Mugo NR, Bukusi EA, de Bruyn G, Irungu E, Celum C, Baeten JM, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study and the Partners PrEP Study.","J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):584-587. doi: 10.1097/QAI.0000000000002505.","Wanga V","J Acquir Immune Defic Syndr","2020","2020/09/25","PMC7654937","","10.1097/QAI.0000000000002505"
"33336213","Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials","Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","medRxiv. 2020 Dec 14:2020.12.14.20248137. doi: 10.1101/2020.12.14.20248137. Preprint.","Follmann D","medRxiv","2020","2020/12/18","PMC7745130","","10.1101/2020.12.14.20248137"
"23945255","Anal sex role segregation and versatility among men who have sex with men: EXPLORE Study","Tieu HV, Li X, Donnell D, Vittinghoff E, Buchbinder S, Parente ZG, Koblin B.","J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):121-5. doi: 10.1097/QAI.0b013e318299cede.","Tieu HV","J Acquir Immune Defic Syndr","2013","2013/08/16","PMC3804162","NIHMS487829","10.1097/QAI.0b013e318299cede"
"31314965","Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART)","Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.","N Engl J Med. 2019 Jul 18;381(3):207-218. doi: 10.1056/NEJMoa1814556.","Hayes RJ","N Engl J Med","2019","2019/07/18","PMC6587177","","10.1056/NEJMoa1814556"
"23129760","HIV incidence determination in the United States: a multiassay approach","Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH.","J Infect Dis. 2013 Jan 15;207(2):232-9. doi: 10.1093/infdis/jis659. Epub 2012 Nov 5.","Laeyendecker O","J Infect Dis","2013","2012/11/07","PMC3532826","","10.1093/infdis/jis659"
"31272495","HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya","Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K.","Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.","Ortblad KF","Trials","2019","2019/07/06","PMC6610957","","10.1186/s13063-019-3521-2"
"34897992","Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial","Klock E, Wilson E, Fernandez RE, Piwowar-Manning E, Moore A, Kosloff B, Bwalya J, Bell-Mandla N, James A, Ayles H, Bock P, Donnell D, Fidler S, Hayes R, Eshleman SH, Laeyendecker O; HPTN071 (PopART) study team.","J Int AIDS Soc. 2021 Dec;24(12):e25830. doi: 10.1002/jia2.25830.","Klock E","J Int AIDS Soc","2021","2021/12/13","PMC8666582","","10.1002/jia2.25830"
"29206720","Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?","Wood D, Lancaster KE, Boily MC, Powers KA, Donnell D, Cohen MS, Dimitrov DT.","J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):350-357. doi: 10.1097/QAI.0000000000001603.","Wood D","J Acquir Immune Defic Syndr","2018","2017/12/06","PMC5825250","NIHMS921995","10.1097/QAI.0000000000001603"
"33208512","Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant","Deese J, Philip N, Lind M, Ahmed K, Batting J, Beksinska M, Edward VA, Louw CE, Onono M, Palanee-Phillips T, Smit JA, Baeten JM, Donnell D, Mastro TD, Mugo NR, Nanda K, Rees H, Morrison C.","Sex Transm Infect. 2021 Jun;97(4):249-255. doi: 10.1136/sextrans-2020-054590. Epub 2020 Nov 18.","Deese J","Sex Transm Infect","2021","2020/11/19","PMC8165154","","10.1136/sextrans-2020-054590"
"28377421","A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples","Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.","Sex Transm Infect. 2017 Nov;93(7):520-529. doi: 10.1136/sextrans-2016-053034. Epub 2017 Apr 4.","Bochner AF","Sex Transm Infect","2017","2017/04/06","","","10.1136/sextrans-2016-053034"
"29240922","Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy","King CC, Ellington SR, Davis NL, Coombs RW, Pyra M, Hong T, Mugo N, Patel RC, Lingappa JR, Baeten JM, Kourtis AP; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.","J Infect Dis. 2017 Dec 19;216(12):1534-1540. doi: 10.1093/infdis/jix550.","King CC","J Infect Dis","2017","2017/12/15","PMC5853287","","10.1093/infdis/jix550"
"25103167","Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial","Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept (HPTN 043) study team.","Lancet Glob Health. 2014 May;2(5):e267-77. doi: 10.1016/S2214-109X(14)70032-4. Epub 2014 Apr 8.","Coates TJ","Lancet Glob Health","2014","2014/08/09","PMC4131207","NIHMS595073","10.1016/S2214-109X(14)70032-4"
"27787340","Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women","Kourtis AP, Wiener J, King CC, Heffron R, Mugo NR, Nanda K, Pyra M, Donnell D, Celum C, Lingappa JR, Baeten JM; Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams.","J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):38-43. doi: 10.1097/QAI.0000000000001199.","Kourtis AP","J Acquir Immune Defic Syndr","2017","2016/10/28","PMC5147030","","10.1097/QAI.0000000000001199"
"32396700","Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial","Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Donnell D, Baeten JM; ECHO Trial Consortium.","J Int AIDS Soc. 2020 May;23(5):e25491. doi: 10.1002/jia2.25491.","Beesham I","J Int AIDS Soc","2020","2020/05/13","PMC7217491","","10.1002/jia2.25491"
"25835607","Determination of HIV Status in African Adults With Discordant HIV Rapid Tests","Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.","J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):430-8. doi: 10.1097/QAI.0000000000000610.","Fogel JM","J Acquir Immune Defic Syndr","2015","2015/04/04","PMC4483143","NIHMS673836","10.1097/QAI.0000000000000610"
"27846073","Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence","Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, Hammer SM, Gilbert PB, Donnell DJ.","J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):606-608. doi: 10.1097/QAI.0000000000001160.","Hanscom B","J Acquir Immune Defic Syndr","2016","2016/11/16","PMC5175411","NIHMS809310","10.1097/QAI.0000000000001160"
"26656786","Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection","Pattacini L, Baeten JM, Thomas KK, Fluharty TR, Murnane PM, Donnell D, Bukusi E, Ronald A, Mugo N, Lingappa JR, Celum C, McElrath MJ, Lund JM; Partners PrEP Study Team.","J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):119-28. doi: 10.1097/QAI.0000000000000919.","Pattacini L","J Acquir Immune Defic Syndr","2016","2015/12/15","PMC4866890","NIHMS742725","10.1097/QAI.0000000000000919"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"31925607","Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa","Wanga V, Baeten JM, Bukusi EA, Mugo NR, Asiimwe S, Ngure K, Mujugira A, Muwonge T, Odoyo JB, Haberer JE, Celum C, Heffron R; Partners Demonstration Project Team.","AIDS Behav. 2020 Jul;24(7):2082-2090. doi: 10.1007/s10461-019-02773-5.","Wanga V","AIDS Behav","2020","2020/01/12","PMC7319874","NIHMS1559268","10.1007/s10461-019-02773-5"
"33844575","A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated","Follmann D, Fintzi J, Fay MP, Janes HE, Baden LR, El Sahly HM, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","Ann Intern Med. 2021 Aug;174(8):1118-1125. doi: 10.7326/M20-8149. Epub 2021 Apr 13.","Follmann D","Ann Intern Med","2021","2021/04/12","PMC8099035","","10.7326/M20-8149"
"36827440","Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study","Beauchamp G, Hosek S, Donnell DJ, Chan KCG, Flaherty BP, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team.","PLoS One. 2023 Feb 24;18(2):e0281728. doi: 10.1371/journal.pone.0281728. eCollection 2023.","Beauchamp G","PLoS One","2023","2023/02/24","PMC9956790","","10.1371/journal.pone.0281728"
"26900902","Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S; MTN-020–ASPIRE Study Team.","N Engl J Med. 2016 Dec 1;375(22):2121-2132. doi: 10.1056/NEJMoa1506110. Epub 2016 Feb 22.","Baeten JM","N Engl J Med","2016","2016/02/23","PMC4993693","NIHMS808397","10.1056/NEJMoa1506110"
"28100808","Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis","Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR.","J Virol. 2017 Jan 18;91(3):e02074-16. doi: 10.1128/JVI.02074-16. Print 2017 Feb 1.","Lund JM","J Virol","2017","2017/01/20","PMC5244339","","10.1128/JVI.02074-16"
"34798031","Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial","Irungu EM, Mugwanya KK, Mugo NR, Bukusi EA, Donnell D, Odoyo J, Wamoni E, Peacock S, Morton JF, Ngure K, Mugambi M, Mukui I, O'Malley G, Baeten JM; Partners Scale-Up Project Team.","Lancet Glob Health. 2021 Dec;9(12):e1730-e1739. doi: 10.1016/S2214-109X(21)00391-0.","Irungu EM","Lancet Glob Health","2021","2021/11/19","PMC8609282","","10.1016/S2214-109X(21)00391-0"
"27708115","Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention","Buchacz K, Farrior J, Beauchamp G, McKinstry L, Kurth AE, Zingman BS, Gordin FM, Donnell D, Mayer KH, El-Sadr WM, Branson B; HPTN 065 Study Team.","J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):81-90. doi: 10.1177/2325957416671410. Epub 2016 Oct 5.","Buchacz K","J Int Assoc Provid AIDS Care","2017","2016/10/07","PMC5621922","NIHMS907593","10.1177/2325957416671410"
"23079806","Hormonal contraceptive use and risk of HIV-1 disease progression","Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, Rees H, Kiarie J, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.","AIDS. 2013 Jan 14;27(2):261-7. doi: 10.1097/QAD.0b013e32835ad473.","Heffron R","AIDS","2013","2012/10/20","PMC3740957","NIHMS494011","10.1097/QAD.0b013e32835ad473"
"21975269","Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study","Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.","Lancet Infect Dis. 2012 Jan;12(1):19-26. doi: 10.1016/S1473-3099(11)70247-X. Epub 2011 Oct 3.","Heffron R","Lancet Infect Dis","2012","2011/10/07","PMC3266951","NIHMS345542","10.1016/S1473-3099(11)70247-X"
"26990823","PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials","Dimitrov DT, Mâsse BR, Donnell D.","J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):444-51. doi: 10.1097/QAI.0000000000000993.","Dimitrov DT","J Acquir Immune Defic Syndr","2016","2016/03/19","PMC4925182","NIHMS766795","10.1097/QAI.0000000000000993"
"36889914","High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial","Delany-Moretlwe S, Mgodi N, Bekker LG, Baeten JM, Li C, Donnell D, Agyei Y, Lennon D, Rose SM, Mokgatle M, Kassim S, Mukaka S, Adeyeye A, Celum C.","Sex Transm Infect. 2023 Mar 8:sextrans-2022-055696. doi: 10.1136/sextrans-2022-055696. Online ahead of print.","Delany-Moretlwe S","Sex Transm Infect","2023","2023/03/08","","","10.1136/sextrans-2022-055696"
"36727597","Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection","Zewdie K, Pickles M, Floyd S, Fidler S, Ayles H, Bock P, Hoddinott G, Mandla N, Shanaube K, Simwinga M, Fraser C, Seeley J, Piwowar-Manning E, Hayes R, Donnell D.","AIDS. 2023 Apr 1;37(5):795-802. doi: 10.1097/QAD.0000000000003463. Epub 2023 Feb 3.","Zewdie K","AIDS","2023","2023/02/02","PMC10023451","NIHMS1857989","10.1097/QAD.0000000000003463"
"24236054","Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial","Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH.","PLoS One. 2013 Nov 13;8(11):e78818. doi: 10.1371/journal.pone.0078818. eCollection 2013.","Laeyendecker O","PLoS One","2013","2013/11/16","PMC3827276","","10.1371/journal.pone.0078818"
"34126052","Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study","Donnell D, Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Rees H, Baeten JM; ECHO Trial Consortium.","Lancet HIV. 2021 Aug;8(8):e495-e501. doi: 10.1016/S2352-3018(21)00048-5. Epub 2021 Jun 11.","Donnell D","Lancet HIV","2021","2021/06/14","PMC8340029","","10.1016/S2352-3018(21)00048-5"
"35835755","Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya","Dabee S, Mugo N, Mudhune V, McLellan-Lemal E, Peacock S, O'Connor S, Njoroge B, Nyagol B, Thurman AR, Ouma E, Ridzon R, Wiener J, Haugen HS, Gasper M, Feng C, Allen SA, Doncel GF, Jaspan HB, Heffron R; Kisumu Combined Ring Study Team.","Sci Rep. 2022 Jul 14;12(1):12040. doi: 10.1038/s41598-022-13475-9.","Dabee S","Sci Rep","2022","2022/07/14","PMC9283538","","10.1038/s41598-022-13475-9"
"36844011","Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083","Mitchell KM, Boily MC, Hanscom B, Moore M, Todd J, Paz-Bailey G, Wejnert C, Liu A, Donnell DJ, Grinsztejn B, Landovitz RJ, Dimitrov DT.","Lancet Reg Health Am. 2023 Jan 17;18:100416. doi: 10.1016/j.lana.2022.100416. eCollection 2023 Feb.","Mitchell KM","Lancet Reg Health Am","2023","2023/02/27","PMC9950652","","10.1016/j.lana.2022.100416"
"32141958","Understanding the HIV Epidemic Among MSM in Baltimore: A Modeling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections","Silhol R, Boily MC, Dimitrov D, German D, Flynn C, Farley JE, Gelman M, Hughes JP, Donnell D, Adeyeye A, Remien RH, Beyrer C, Paz-Bailey G, Wejnert C, Mitchell KM.","J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):253-262. doi: 10.1097/QAI.0000000000002340.","Silhol R","J Acquir Immune Defic Syndr","2020","2020/03/07","PMC8432604","","10.1097/QAI.0000000000002340"
"23056215","Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men","Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP.","PLoS One. 2012;7(10):e45718. doi: 10.1371/journal.pone.0045718. Epub 2012 Oct 3.","Vallabhaneni S","PLoS One","2012","2012/10/12","PMC3463589","","10.1371/journal.pone.0045718"
"32072743","Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)","Eshleman SH, Piwowar-Manning E, Wilson EA, Lennon D, Fogel JM, Agyei Y, Sullivan PA, Weng L, Moore A, Laeyendecker O, Kosloff B, Bwalya J, Maarman G, van Deventer A, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D; HPTN 071 (PopART) Study Team.","J Int AIDS Soc. 2020 Feb;23(2):e25452. doi: 10.1002/jia2.25452.","Eshleman SH","J Int AIDS Soc","2020","2020/02/20","PMC7028526","","10.1002/jia2.25452"
"35990584","PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial","Heffron R, Muwonge TR, Thomas KK, Nambi F, Nakabugo L, Kibuuka J, Thomas D, Feutz E, Meisner A, Ware NC, Wyatt MA, Simoni JM, Katz IT, Kadama H, Baeten JM, Mujugira A; Partners PrEP Program Team.","EClinicalMedicine. 2022 Aug 11;52:101611. doi: 10.1016/j.eclinm.2022.101611. eCollection 2022 Oct.","Heffron R","EClinicalMedicine","2022","2022/08/22","PMC9386395","","10.1016/j.eclinm.2022.101611"
"25564105","Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058","Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team.","J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554-61. doi: 10.1097/QAI.0000000000000510.","Metzger DS","J Acquir Immune Defic Syndr","2015","2015/01/08","PMC4382671","NIHMS651868","10.1097/QAI.0000000000000510"
"25520426","Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons","Pattacini L, Murnane PM, Baeten JM, Fluharty TR, Thomas KK, Bukusi E, Katabira E, Mugo N, Donnell D, Lingappa JR, Celum C, Marzinke M, McElrath MJ, Lund JM; Partners PrEP Study Team.","J Infect Dis. 2015 Jun 15;211(12):1943-52. doi: 10.1093/infdis/jiu815. Epub 2014 Dec 17.","Pattacini L","J Infect Dis","2015","2014/12/19","PMC4836720","","10.1093/infdis/jiu815"
"35710444","Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial","Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, Celum C, Odoyo J, Kwena ZA, Scoville CW, Violette LR, Morrison S, Simoni J, McClelland RS, Barnabas R, Gandhi M, Baeten JM.","Trials. 2022 Jun 16;23(1):495. doi: 10.1186/s13063-022-06458-8.","Stewart J","Trials","2022","2022/06/16","PMC9201793","","10.1186/s13063-022-06458-8"
"22785188","Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity","Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD.","J Clin Microbiol. 2012 Sep;50(9):3054-9. doi: 10.1128/JCM.01460-12. Epub 2012 Jul 11.","Cousins MM","J Clin Microbiol","2012","2012/07/13","PMC3421787","","10.1128/JCM.01460-12"
"34473700","PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial","Pickles M, Cori A, Probert WJM, Sauter R, Hinch R, Fidler S, Ayles H, Bock P, Donnell D, Wilson E, Piwowar-Manning E, Floyd S, Hayes RJ, Fraser C; HPTN 071 (PopART) Study Team.","PLoS Comput Biol. 2021 Sep 2;17(9):e1009301. doi: 10.1371/journal.pcbi.1009301. eCollection 2021 Sep.","Pickles M","PLoS Comput Biol","2021","2021/09/02","PMC8478209","","10.1371/journal.pcbi.1009301"
"36332653","Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial","Wilson E, Donnell D, Skalland T, Floyd S, Moore A, Bell-Mandla N, Bwalya J, Kasese N, Dunbar R, Shanaube K, Kosloff B, Laeyendecker O, Agyei Y, Hoddinott G, Bock P, Fidler S, Hayes R, Ayles H; HPTN 071 (PopART) Study Team.","Lancet HIV. 2022 Nov;9(11):e760-e770. doi: 10.1016/S2352-3018(22)00253-3.","Wilson E","Lancet HIV","2022","2022/11/04","PMC9646971","","10.1016/S2352-3018(22)00253-3"
"36332652","Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis","Macleod D, Shanaube K, Skalland T, Limbada M, Mandla N, Bwalya J, Schaap A, Yang B, Donnell D, Piwowar-Manning E, Eshleman SH, Hoddinott G, Bond V, Moore A, Griffith S, Bock P, Ayles H, Fidler S, Hayes R, Floyd S; HPTN 071 (PopART) Study Team.","Lancet HIV. 2022 Nov;9(11):e751-e759. doi: 10.1016/S2352-3018(22)00237-5.","Macleod D","Lancet HIV","2022","2022/11/04","PMC9646982","","10.1016/S2352-3018(22)00237-5"
"23764624","Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions","Donnell D, Hughes JP, Wang L, Chen YQ, Fleming TR.","J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S130-4. doi: 10.1097/QAI.0b013e3182986fac.","Donnell D","J Acquir Immune Defic Syndr","2013","2013/06/15","PMC3725298","NIHMS485408","10.1097/QAI.0b013e3182986fac"
"36087612","Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial","Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C.","Lancet HIV. 2022 Oct;9(10):e680-e689. doi: 10.1016/S2352-3018(22)00195-3. Epub 2022 Sep 7.","Velloza J","Lancet HIV","2022","2022/09/10","PMC9530001","NIHMS1836627","10.1016/S2352-3018(22)00195-3"
"32394723","Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression","Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, Beesham I, Stringer JSA, Baeten JM, Ahmed K; ECHO Trial Team.","AIDS Res Hum Retroviruses. 2020 Aug;36(8):632-640. doi: 10.1089/AID.2020.0015. Epub 2020 Jun 2.","Morrison CS","AIDS Res Hum Retroviruses","2020","2020/05/13","PMC7414801","","10.1089/AID.2020.0015"
"25455979","Choosing a metric for measurement of pre-exposure prophylaxis","Emerson R, Emerson S, Donnell D, Hughes JP.","Lancet Infect Dis. 2014 Dec;14(12):1177. doi: 10.1016/S1473-3099(14)70984-3. Epub 2014 Nov 17.","Emerson R","Lancet Infect Dis","2014","2014/12/03","","","10.1016/S1473-3099(14)70984-3"
"29557855","Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058","Shava E, Lipira LE, Beauchamp GG, Donnell DJ, Lockman S, Ruan Y, Shao Y.","J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):300-307. doi: 10.1097/QAI.0000000000001683.","Shava E","J Acquir Immune Defic Syndr","2018","2018/03/21","PMC5997518","NIHMS951940","10.1097/QAI.0000000000001683"
"24853311","An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda","Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA.","J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9. doi: 10.1097/QAI.0000000000000212.","Psaros C","J Acquir Immune Defic Syndr","2014","2014/05/24","PMC4191829","NIHMS593008","10.1097/QAI.0000000000000212"
"37370143","Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study","Bell-Mandla N, Wilson E, Sharma D, Sloot R, Bwalya J, Schaap A, Donnell D, Piwowar-Manning E, Floyd S, Makola N, Nkonki L, Simwinga M, Moore A, Hayes R, Fidler S, Ayles H, Bock P; HPTN 071 (PopART) Study Team.","Trials. 2023 Jun 27;24(1):434. doi: 10.1186/s13063-023-07404-y.","Bell-Mandla N","Trials","2023","2023/06/27","PMC10294466","","10.1186/s13063-023-07404-y"
"21471433","Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission","Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, Campbell MS, Mullins JI, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.","Sci Transl Med. 2011 Apr 6;3(77):77ra29. doi: 10.1126/scitranslmed.3001888.","Baeten JM","Sci Transl Med","2011","2011/04/08","PMC3087186","NIHMS283752","10.1126/scitranslmed.3001888"
"21785321","Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples","Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR, Kayintekore K, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.","AIDS. 2011 Sep 24;25(15):1887-95. doi: 10.1097/QAD.0b013e32834a9338.","Mugo NR","AIDS","2011","2011/07/26","PMC3173565","NIHMS307217","10.1097/QAD.0b013e32834a9338"
"25935214","Assessment of contamination and misclassification biases in a randomized controlled trial of a social network peer education intervention to reduce HIV risk behaviors among drug users and risk partners in Philadelphia, PA and Chiang Mai, Thailand","Simmons N, Donnell D, Ou SS, Celentano DD, Aramrattana A, Davis-Vogel A, Metzger D, Latkin C.","AIDS Behav. 2015 Oct;19(10):1818-27. doi: 10.1007/s10461-015-1073-3.","Simmons N","AIDS Behav","2015","2015/05/04","PMC4567413","NIHMS707053","10.1007/s10461-015-1073-3"
"30006791","Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships","Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM; Partners Demonstration Project Team.","AIDS Behav. 2018 Nov;22(11):3718-3725. doi: 10.1007/s10461-018-2221-3.","Pyra M","AIDS Behav","2018","2018/07/15","PMC6330257","NIHMS981476","10.1007/s10461-018-2221-3"
"33285419","Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials","Mitchell KM, Dimitrov D, Hughes JP, Moore M, Vittinghoff E, Liu A, Cohen MS, Beyrer C, Donnell D, Boily MC.","Epidemics. 2020 Dec;33:100423. doi: 10.1016/j.epidem.2020.100423. Epub 2020 Nov 20.","Mitchell KM","Epidemics","2020","2020/12/07","PMC7938213","NIHMS1657598","10.1016/j.epidem.2020.100423"
"27828875","Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043)","Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH, Chingono AH.","J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):158-165. doi: 10.1097/QAI.0000000000001229.","Fogel JM","J Acquir Immune Defic Syndr","2017","2016/11/10","PMC5233465","NIHMS825579","10.1097/QAI.0000000000001229"
"32773484","The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa","Stangl AL, Pliakas T, Mainga T, Steinhaus M, Mubekapi-Musadaidzwa C, Viljoen L, Dunbar R, Schaap A, Floyd S, Mandla N, Bond V, Hoddinott G, Fidler S, Hayes R, Ayles H, Bock P, Donnell D, Hargreaves JR; HPTN 071 (PopART) study team.","AIDS. 2020 Nov 15;34(14):2125-2135. doi: 10.1097/QAD.0000000000002658.","Stangl AL","AIDS","2020","2020/08/11","PMC8425632","NIHMS1740107","10.1097/QAD.0000000000002658"
"24121753","Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival","Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Allen M, Jackson JB, Fowler MG, Guay LA.","J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):464-71. doi: 10.1097/QAI.0000000000000015.","Owor M","J Acquir Immune Defic Syndr","2013","2013/10/15","PMC4172334","NIHMS542850","10.1097/QAI.0000000000000015"
"21533179","Association of HIV diversity and survival in HIV-infected Ugandan infants","James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH.","PLoS One. 2011 Apr 14;6(4):e18642. doi: 10.1371/journal.pone.0018642.","James MM","PLoS One","2011","2011/05/03","PMC3077388","","10.1371/journal.pone.0018642"
"37363917","Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women","Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S.","J Int AIDS Soc. 2023 Jun;26(6):e26118. doi: 10.1002/jia2.26118.","Donnell D","J Int AIDS Soc","2023","2023/06/26","PMC10292682","","10.1002/jia2.26118"
"37208687","Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study","Beauchamp G, Donnell D, Hosek S, Anderson PL, Chan KCG, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C.","BMC Womens Health. 2023 May 19;23(1):276. doi: 10.1186/s12905-023-02418-9.","Beauchamp G","BMC Womens Health","2023","2023/05/19","PMC10199602","","10.1186/s12905-023-02418-9"
"33136739","Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression","Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D.","J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):423-429. doi: 10.1097/QAI.0000000000002481.","Moore JR","J Acquir Immune Defic Syndr","2020","2020/11/02","PMC7670079","NIHMS1622381","10.1097/QAI.0000000000002481"
"31437276","Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT Study","Dimitrov D, Moore JR, Wood D, Mitchell KM, Li M, Hughes JP, Donnell DJ, Mannheimer S, Holtz TH, Grant RM, Boily MC.","Clin Infect Dis. 2020 Jul 11;71(2):249-255. doi: 10.1093/cid/ciz799.","Dimitrov D","Clin Infect Dis","2020","2019/08/23","PMC7353329","","10.1093/cid/ciz799"
"23801018","Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting","Baisley K, Baeten JM, Hughes JP, Donnell DJ, Wang J, Hayes R, Watson Jones D, Celum C.","AIDS Behav. 2013 Nov;17(9):3108-19. doi: 10.1007/s10461-013-0542-9.","Baisley K","AIDS Behav","2013","2013/06/27","PMC3812335","NIHMS492074","10.1007/s10461-013-0542-9"
"21390540","Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE","Bedoya CA, Mimiaga MJ, Beauchamp G, Donnell D, Mayer KH, Safren SA.","AIDS Behav. 2012 Apr;16(3):608-17. doi: 10.1007/s10461-011-9911-4.","Bedoya CA","AIDS Behav","2012","2011/03/11","PMC3632284","NIHMS461586","10.1007/s10461-011-9911-4"
"21073438","Analysis of HIV tropism in Ugandan infants","Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, Fowler MG, Eshleman SH.","Curr HIV Res. 2010 Oct;8(7):498-503. doi: 10.2174/157016210793499187.","Church JD","Curr HIV Res","2010","2010/11/16","PMC3075545","NIHMS250647","10.2174/157016210793499187"
"26914909","Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis","Mugwanya KK, Wyatt C, Celum C, Donnell D, Kiarie J, Ronald A, Baeten JM; Partners PrEP Study Team.","J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):374-80. doi: 10.1097/QAI.0000000000000868.","Mugwanya KK","J Acquir Immune Defic Syndr","2016","2016/02/26","PMC4770857","NIHMS728270","10.1097/QAI.0000000000000868"
"37270546","Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention","Oware K, Adiema L, Rono B, Violette LR, McClelland RS, Donnell D, Scoville CW, Odoyo J, Baeten JM, Bukusi E, Stewart J.","BMC Womens Health. 2023 Jun 3;23(1):296. doi: 10.1186/s12905-023-02413-0.","Oware K","BMC Womens Health","2023","2023/06/03","PMC10239600","","10.1186/s12905-023-02413-0"
"34330945","COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact","Swan DA, Bracis C, Janes H, Moore M, Matrajt L, Reeves DB, Burns E, Donnell D, Cohen MS, Schiffer JT, Dimitrov D.","Sci Rep. 2021 Jul 30;11(1):15531. doi: 10.1038/s41598-021-94719-y.","Swan DA","Sci Rep","2021","2021/07/31","PMC8324774","","10.1038/s41598-021-94719-y"
"22348195","Experience in international clinical research: the HIV Prevention Trials Network","Sista ND, Abdool Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH.","Clin Investig (Lond). 2011 Dec;1(12):1609-1618. doi: 10.4155/cli.11.156.","Sista ND","Clin Investig (Lond)","2011","2012/02/21","PMC3281583","NIHMS352766","10.4155/cli.11.156"
"37439080","Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis","Stansfield SE, Heitner J, Mitchell KM, Doyle CM, Milwid RM, Moore M, Donnell DJ, Hanscom B, Xia Y, Maheu-Giroux M, Vijver DV, Wang H, Barnabas R, Boily MC, Dimitrov DT.","J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26109. doi: 10.1002/jia2.26109.","Stansfield SE","J Int AIDS Soc","2023","2023/07/13","PMC10339001","","10.1002/jia2.26109"
"27558421","HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis","Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR.","J Virol. 2016 Oct 14;90(21):9855-9861. doi: 10.1128/JVI.01482-16. Print 2016 Nov 1.","Lund JM","J Virol","2016","2016/08/26","PMC5068535","","10.1128/JVI.01482-16"
"22869103","Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence","Donnell DJ, Baeten JM, Hong T, Lingappa JR, Mujugira A, Nakku-Joloba E, Bangsberg D, Celum C.","AIDS Behav. 2013 Feb;17(2):632-9. doi: 10.1007/s10461-012-0268-0.","Donnell DJ","AIDS Behav","2013","2012/08/08","PMC3721974","NIHMS399200","10.1007/s10461-012-0268-0"
"20844744","Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort","Philip SS, Yu X, Donnell D, Vittinghoff E, Buchbinder S.","PLoS One. 2010 Sep 9;5(9):e12662. doi: 10.1371/journal.pone.0012662.","Philip SS","PLoS One","2010","2010/09/17","PMC2936578","","10.1371/journal.pone.0012662"
"33587510","A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings","Mgodi NM, Takuva S, Edupuganti S, Karuna S, Andrew P, Lazarus E, Garnett P, Shava E, Mukwekwerere PG, Kochar N, Marshall K, Rudnicki E, Juraska M, Anderson M, Karg C, Tindale I, Greene E, Luthuli N, Baepanye K, Hural J, Gomez Lorenzo MM, Burns D, Miner MD, Ledgerwood J, Mascola JR, Donnell D, Cohen MS, Corey L; HVTN 703/HPTN 081 Team.","J Acquir Immune Defic Syndr. 2021 May 1;87(1):680-687. doi: 10.1097/QAI.0000000000002649.","Mgodi NM","J Acquir Immune Defic Syndr","2021","2021/02/15","PMC8436719","NIHMS1735905","10.1097/QAI.0000000000002649"
"28899162","High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy","Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R.","AIDS Res Hum Retroviruses. 2018 Feb;34(2):140-147. doi: 10.1089/aid.2017.0020. Epub 2017 Sep 13.","Mujugira A","AIDS Res Hum Retroviruses","2018","2017/09/14","PMC5806074","","10.1089/aid.2017.0020"
"29355224","Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study)","Hofmeyr GJ, Morrison CS, Baeten JM, Chipato T, Donnell D, Gichangi P, Mugo N, Nanda K, Rees H, Steyn P, Taylor D; ECHO Trial Team.","Gates Open Res. 2018 Mar 13;1:17. doi: 10.12688/gatesopenres.12775.2. eCollection 2017.","Hofmeyr GJ","Gates Open Res","2018","2019/09/25","PMC5771152","","10.12688/gatesopenres.12775.2"
"27552090","Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda","Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, Ware NC, Wyatt MA, Morrison S, Haugen H, Mujugira A, Donnell D, Celum C; Partners Demonstration Project Team.","PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.","Baeten JM","PLoS Med","2016","2016/08/24","PMC4995047","","10.1371/journal.pmed.1002099"
"28453835","Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study","Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, Hakim J, Kumarasamy N, Campbell TB; ACTG PEARLS/A5175 Team.","J Infect Dis. 2017 Mar 15;215(6):907-910. doi: 10.1093/infdis/jix029.","Celum C","J Infect Dis","2017","2017/04/29","PMC5406847","","10.1093/infdis/jix029"
"28589504","Age-Related Differences in Socio-demographic and Behavioral Determinants of HIV Testing and Counseling in HPTN 043/NIMH Project Accept","Salazar-Austin N, Kulich M, Chingono A, Chariyalertsak S, Srithanaviboonchai K, Gray G, Richter L, van Rooyen H, Morin S, Sweat M, Mbwambo J, Szekeres G, Coates T, Celentano D; NIMH Project Accept (HPTN 043) Study Team.","AIDS Behav. 2018 Feb;22(2):569-579. doi: 10.1007/s10461-017-1807-5.","Salazar-Austin N","AIDS Behav","2018","2017/06/08","PMC5718984","NIHMS895642","10.1007/s10461-017-1807-5"
"34164929","Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial","Velloza J, Hosek S, Donnell D, Anderson PL, Chirenje M, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study group.","J Int AIDS Soc. 2021 Jun;24 Suppl 2(Suppl 2):e25731. doi: 10.1002/jia2.25731.","Velloza J","J Int AIDS Soc","2021","2021/06/24","PMC8222844","","10.1002/jia2.25731"
"23187945","An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention","Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, Nakku-Joloba E, Njuguna S, Mugo N, Bukusi E, Manongi R, Baeten JM; Partners in Prevention HSVHIV Transmission Study and the Partners PrEP Study Teams.","J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):339-47. doi: 10.1097/QAI.0b013e31827e622d.","Kahle EM","J Acquir Immune Defic Syndr","2013","2012/11/29","PMC3620695","NIHMS429909","10.1097/QAI.0b013e31827e622d"
"22785048","Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children","James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH.","Pediatr Infect Dis J. 2012 Nov;31(11):e222-8. doi: 10.1097/INF.0b013e3182678c3f.","James MM","Pediatr Infect Dis J","2012","2012/07/13","PMC3473149","NIHMS398242","10.1097/INF.0b013e3182678c3f"
"25501609","The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men","Mimiaga MJ, OʼCleirigh C, Biello KB, Robertson AM, Safren SA, Coates TJ, Koblin BA, Chesney MA, Donnell DJ, Stall RD, Mayer KH.","J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):329-36. doi: 10.1097/QAI.0000000000000475.","Mimiaga MJ","J Acquir Immune Defic Syndr","2015","2014/12/16","PMC4415161","NIHMS645552","10.1097/QAI.0000000000000475"
"33721566","Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial","Thomas R, Probert WJM, Sauter R, Mwenge L, Singh S, Kanema S, Vanqa N, Harper A, Burger R, Cori A, Pickles M, Bell-Mandla N, Yang B, Bwalya J, Phiri M, Shanaube K, Floyd S, Donnell D, Bock P, Ayles H, Fidler S, Hayes RJ, Fraser C, Hauck K; HPTN 071 (PopART) study team.","Lancet Glob Health. 2021 May;9(5):e668-e680. doi: 10.1016/S2214-109X(21)00034-6. Epub 2021 Mar 12.","Thomas R","Lancet Glob Health","2021","2021/03/15","PMC8050197","","10.1016/S2214-109X(21)00034-6"
"20537376","Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis","Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.","Lancet. 2010 Jun 12;375(9731):2092-8. doi: 10.1016/S0140-6736(10)60705-2. Epub 2010 May 26.","Donnell D","Lancet","2010","2010/06/12","PMC2922041","NIHMS215541","10.1016/S0140-6736(10)60705-2"
"20856886","Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk","Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.","PLoS One. 2010 Sep 13;5(9):e12598. doi: 10.1371/journal.pone.0012598.","Lingappa JR","PLoS One","2010","2010/09/22","PMC2938354","","10.1371/journal.pone.0012598"
"30406335","Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study","Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE; Partners Mobile Adherence to PrEP (PMAP) Team.","AIDS Behav. 2019 May;23(5):1267-1276. doi: 10.1007/s10461-018-2326-8.","Muwonge TR","AIDS Behav","2019","2018/11/09","PMC6504627","NIHMS1511864","10.1007/s10461-018-2326-8"
"21963939","Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships","Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, Delany-Moretlwe S, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.","J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):65-71. doi: 10.1097/QAI.0b013e318237b864.","Ndase P","J Acquir Immune Defic Syndr","2012","2011/10/04","PMC3237862","NIHMS332237","10.1097/QAI.0b013e318237b864"
"25542477","Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa","Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.","J Clin Virol. 2015 Jan;62:75-9. doi: 10.1016/j.jcv.2014.11.023. Epub 2014 Nov 27.","Piwowar-Manning E","J Clin Virol","2015","2014/12/28","PMC4319362","NIHMS650377","10.1016/j.jcv.2014.11.023"
"34143779","PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial","Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, Pathak S, Mgodi N, Bekker LG, Donnell DJ, Wilson E, Yuha K, Anderson PL, Agyei Y, Noble H, Rose SM, Baeten JM, Fogel JM, Adeyeye A, Wiesner L, Rooney J, Delany-Moretlwe S.","PLoS Med. 2021 Jun 18;18(6):e1003670. doi: 10.1371/journal.pmed.1003670. eCollection 2021 Jun.","Celum C","PLoS Med","2021","2021/06/18","PMC8253429","","10.1371/journal.pmed.1003670"
"24139639","Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis","Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, Katabira E, Ngure K, Baeten JM; Partners PrEP Study Team.","Lancet Infect Dis. 2013 Dec;13(12):1021-8. doi: 10.1016/S1473-3099(13)70226-3. Epub 2013 Oct 17.","Mugwanya KK","Lancet Infect Dis","2013","2013/10/22","PMC3920826","NIHMS542625","10.1016/S1473-3099(13)70226-3"
"28894986","Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples","Heffron R, Thomson K, Celum C, Haberer J, Ngure K, Mugo N, Bukusi E, Katabira E, Odoyo J, Bulya N, Asiimwe S, Tindimwebwa E, Baeten JM; Partners Demonstration Project Team.","AIDS Behav. 2018 Jun;22(6):1758-1765. doi: 10.1007/s10461-017-1902-7.","Heffron R","AIDS Behav","2018","2017/09/13","PMC5845763","NIHMS905649","10.1007/s10461-017-1902-7"
"26414912","Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)","Hendrix CW, Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I, Radebaugh C, Prince HA, Bakshi RP, Wang R, Richardson P, Shieh E, McKinstry L, Li X, Donnell D, Elharrar V, Mayer KH, Patterson KB.","AIDS Res Hum Retroviruses. 2016 Jan;32(1):32-43. doi: 10.1089/AID.2015.0182. Epub 2015 Oct 15.","Hendrix CW","AIDS Res Hum Retroviruses","2016","2015/09/29","PMC4692123","","10.1089/AID.2015.0182"
"22926009","Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1","Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, Essex M, McElrath MJ, Nakku-Joloba E, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.","J Infect Dis. 2012 Oct;206(8):1299-308. doi: 10.1093/infdis/jis480. Epub 2012 Aug 27.","Mackelprang RD","J Infect Dis","2012","2012/08/29","PMC3448964","","10.1093/infdis/jis480"
"24860664","Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand","Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G, Donnell D, Ruan Y, Ma L, Metzger D, Shao Y.","Hepat Res Treat. 2014;2014:296958. doi: 10.1155/2014/296958. Epub 2014 Mar 27.","Jackson JB","Hepat Res Treat","2014","2014/05/27","PMC3985324","","10.1155/2014/296958"
"33823907","How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa","Bond V, Hoddinott G, Viljoen L, Ngwenya F, Simuyaba M, Chiti B, Ndubani R, Makola N, Donnell D, Schaap A, Floyd S, Hargreaves J, Shanaube K, Fidler S, Bock P, Ayles H, Hayes R, Simwinga M, Seeley J; HPTN071 (PopART) study team.","Trials. 2021 Apr 6;22(1):251. doi: 10.1186/s13063-021-05198-5.","Bond V","Trials","2021","2021/04/07","PMC8025534","","10.1186/s13063-021-05198-5"
"24489841","NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members","Maman S, van Rooyen H, Stankard P, Chingono A, Muravha T, Ntogwisangu J, Phakathi Z, Srirak N, F Morin S; NIMH Project Accept (HPTN 043) study team.","PLoS One. 2014 Jan 29;9(1):e87091. doi: 10.1371/journal.pone.0087091. eCollection 2014.","Maman S","PLoS One","2014","2014/02/04","PMC3906114","","10.1371/journal.pone.0087091"
"32991336","HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South Africa","Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D, Piwowar-Manning E, Agyei Y, Mandla NF, Dunbar R, Macleod D, Floyd S, Bock P, Fidler S, Hayes RJ, Seeley J, Stangl A, Bond V, Ayles H; HPTN 071 (PopART) Study Team.","J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):561-570. doi: 10.1097/QAI.0000000000002504.","Hargreaves JR","J Acquir Immune Defic Syndr","2020","2020/09/29","PMC7654947","","10.1097/QAI.0000000000002504"
"23695519","Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women","Curran K, Mugo NR, Kurth A, Ngure K, Heffron R, Donnell D, Celum C, Baeten JM.","AIDS Behav. 2013 Nov;17(9):2977-85. doi: 10.1007/s10461-013-0510-4.","Curran K","AIDS Behav","2013","2013/05/23","PMC3812384","NIHMS483689","10.1007/s10461-013-0510-4"
"32745296","Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa","Jones HS, Floyd S, Stangl A, Bond V, Hoddinott G, Pliakas T, Bwalya J, Mandla N, Moore A, Donnell D, Bock P, Fidler S, Hayes R, Ayles H, Hargreaves JR; HPTN 071 (PopART) Study Team.","Trop Med Int Health. 2020 Oct;25(10):1246-1260. doi: 10.1111/tmi.13473. Epub 2020 Aug 26.","Jones HS","Trop Med Int Health","2020","2020/08/04","PMC7590062","","10.1111/tmi.13473"
"31194704","Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study","El-Sadr WM, Beauchamp G, Hall HI, Torian LV, Zingman BS, Lum G, Elion RA, Buchacz K, Burns D, Zerbe A, Gamble T, Donnell DJ; HPTN 065 Study.","J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):300-303. doi: 10.1097/QAI.0000000000001927.","El-Sadr WM","J Acquir Immune Defic Syndr","2019","2019/06/14","PMC6587372","","10.1097/QAI.0000000000001927"
"28628702","Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065)","El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, Lum G, Kharfen M, Elion R, Leider J, Gordin FM, Elharrar V, Burns D, Zerbe A, Gamble T, Branson B; HPTN 065 Study Team.","JAMA Intern Med. 2017 Aug 1;177(8):1083-1092. doi: 10.1001/jamainternmed.2017.2158.","El-Sadr WM","JAMA Intern Med","2017","2017/06/20","PMC5604092","","10.1001/jamainternmed.2017.2158"
"28627929","Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States","Gamble T, Branson B, Donnell D, Hall HI, King G, Cutler B, Hader S, Burns D, Leider J, Wood AF, G Volpp K, Buchacz K, El-Sadr WM; HPTN 065 Study Team.","Clin Trials. 2017 Aug;14(4):322-332. doi: 10.1177/1740774517711682. Epub 2017 Jun 19.","Gamble T","Clin Trials","2017","2017/06/20","PMC5639958","","10.1177/1740774517711682"
"31182536","Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa","Mallayasamy S, Chaturvedula A, Fossler MJ, Sale M, Goti V, Bumpus NN, Marzinke MA, Hendrix CW, Haberer JE; Partners Demonstration Project Team.","Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00446-19. doi: 10.1128/AAC.00446-19. Print 2019 Aug.","Mallayasamy S","Antimicrob Agents Chemother","2019","2019/06/12","PMC6658796","","10.1128/AAC.00446-19"
"29369164","Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study","Hargreaves JR, Krishnaratne S, Mathema H, Lilleston PS, Sievwright K, Mandla N, Mainga T, Vermaak R, Piwowar-Manning E, Schaap A, Donnell D, Ayles H, Hayes RJ, Hoddinott G, Bond V, Stangl A; HPTN 071 (PopART) Study Team.","AIDS. 2018 Mar 27;32(6):783-793. doi: 10.1097/QAD.0000000000001757.","Hargreaves JR","AIDS","2018","2018/01/26","PMC5854764","NIHMS939281","10.1097/QAD.0000000000001757"
"30180860","Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya","Mugwanya KK, Irungu E, Bukusi E, Mugo NR, Odoyo J, Wamoni E, Ngure K, Morton JF, Peebles K, Masyuko S, Barnabee G, Donnell D, Barnabas R, Haberer J, O'Malley G, Baeten JM; Partners Scale Up Team.","Implement Sci. 2018 Sep 4;13(1):118. doi: 10.1186/s13012-018-0809-7.","Mugwanya KK","Implement Sci","2018","2018/09/06","PMC6123996","","10.1186/s13012-018-0809-7"
"32105625","Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial","Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N, Ngobese H, Mlisana K, Moodley P, Donnell D, Barnabas RV, Naidoo K, Abdool Karim SS, Celum C, Garrett N.","Lancet HIV. 2020 Apr;7(4):e229-e237. doi: 10.1016/S2352-3018(19)30402-3. Epub 2020 Feb 24.","Drain PK","Lancet HIV","2020","2020/02/28","PMC7183312","NIHMS1567480","10.1016/S2352-3018(19)30402-3"
"30868739","Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078","Mitchell KM, Hoots B, Dimitrov D, German D, Flynn C, Farley JE, Gelman M, Hughes JP, Donnell D, Adeyeye A, Remien RH, Beyrer C, Paz-Bailey G, Boily MC.","J Int AIDS Soc. 2019 Mar;22(3):e25246. doi: 10.1002/jia2.25246.","Mitchell KM","J Int AIDS Soc","2019","2019/03/15","PMC6416473","","10.1002/jia2.25246"
"27751179","Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention","Irungu EM, Heffron R, Mugo N, Ngure K, Katabira E, Bulya N, Bukusi E, Odoyo J, Asiimwe S, Tindimwebwa E, Celum C, Baeten JM; Partners Demonstration Project Team.","BMC Infect Dis. 2016 Oct 17;16(1):571. doi: 10.1186/s12879-016-1899-y.","Irungu EM","BMC Infect Dis","2016","2016/10/19","PMC5067880","","10.1186/s12879-016-1899-y"
"20042848","Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples","Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.","AIDS. 2010 Mar 13;24(5):737-44. doi: 10.1097/QAD.0b013e32833616e0.","Baeten JM","AIDS","2010","2010/01/01","PMC2919808","NIHMS219039","10.1097/QAD.0b013e32833616e0"
"31840400","Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa","Stangl AL, Lilleston P, Mathema H, Pliakas T, Krishnaratne S, Sievwright K, Bell-Mandla N, Vermaak R, Mainga T, Steinhaus M, Donnell D, Schaap A, Bock P, Ayles H, Hayes R, Hoddinott G, Bond V, Hargreaves JR; HPTN 071 (PopART) Study Team.","J Int AIDS Soc. 2019 Dec;22(12):e25421. doi: 10.1002/jia2.25421.","Stangl AL","J Int AIDS Soc","2019","2019/12/17","PMC6912047","","10.1002/jia2.25421"
"24413311","HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples","Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R, Mujugira A, Fife K, Mugo N, Kapiga S, Mullins JI, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.","AIDS. 2014 Jan 14;28(2):235-43. doi: 10.1097/QAD.0000000000000024.","Kahle E","AIDS","2014","2014/01/14","PMC4090091","NIHMS595286","10.1097/QAD.0000000000000024"
"24828268","Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience","Ndase P, Celum C, Campbell J, Bukusi E, Kiarie J, Katabira E, Mugo N, Tumwesigye E, Wangisi J, Were E, Brantley J, Donnell D, Baeten JM.","J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):206-12. doi: 10.1097/QAI.0000000000000141.","Ndase P","J Acquir Immune Defic Syndr","2014","2014/05/16","","","10.1097/QAI.0000000000000141"
"29355231","Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa","Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo NR, Bukusi EA, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, Mujugira A, Haberer JE, Ware NC, Wyatt MA, Marzinke MA, Frenkel LM, Celum C, Baeten JM; Partners Demonstration Project Team.","Gates Open Res. 2018 Jan 30;1:3. doi: 10.12688/gatesopenres.12752.2. eCollection 2017.","Heffron R","Gates Open Res","2018","2019/09/25","PMC5757790","","10.12688/gatesopenres.12752.2"
"28872272","Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa","Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A, James A, Schaap A, Scheepers M, Donnell D, Griffith S, El-Sadr W, Shanaube K, Beyers N, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) Study Team.","J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21780. doi: 10.7448/IAS.20.7.21780.","Bock P","J Int AIDS Soc","2017","2017/09/06","PMC5625636","","10.7448/IAS.20.7.21780"
"23049660","Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065","Donnell DJ, Hall HI, Gamble T, Beauchamp G, Griffin AB, Torian LV, Branson B, El-Sadr WM.","Open AIDS J. 2012;6:122-30. doi: 10.2174/1874613601206010122. Epub 2012 Sep 7.","Donnell DJ","Open AIDS J","2012","2012/10/11","PMC3462339","","10.2174/1874613601206010122"
"24999060","Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand","Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D; HPTN 058 study group.","Drug Alcohol Depend. 2014 Sep 1;142:139-45. doi: 10.1016/j.drugalcdep.2014.06.013. Epub 2014 Jun 19.","Lucas GM","Drug Alcohol Depend","2014","2014/07/08","PMC4127183","NIHMS611372","10.1016/j.drugalcdep.2014.06.013"
"22813645","Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples","Chen YQ, Masse B, Wang L, Ou SS, Li X, Donnell D, McCauley M, Gamble T, Ribauldo HJ, Cohen MS, Fleming TR.","Contemp Clin Trials. 2012 Nov;33(6):1280-6. doi: 10.1016/j.cct.2012.07.007. Epub 2012 Jul 16.","Chen YQ","Contemp Clin Trials","2012","2012/07/21","PMC3468650","NIHMS394596","10.1016/j.cct.2012.07.007"
"30350406","Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis","Lancaster KE, Hoffman IF, Hanscom B, Ha TV, Dumchev K, Susami H, Rose S, Go VF, Reifeis SA, Mollan KR, Hudgens MG, Piwowar-Manning EM, Richardson P, Dvoriak S, Djoerban Z, Kiriazova T, Zeziulin O, Djauzi S, Ahn CV, Latkin C, Metzger D, Burns DN, Sugarman J, Strathdee SA, Eshleman SH, Clarke W, Donnell D, Emel L, Sunner LE, McKinstry L, Sista N, Hamilton EL, Lucas JP, Duong BD, Van Vuong N, Sarasvita R, Miller WC; HPTN 074 Study Team.","J Int AIDS Soc. 2018 Oct;21(10):e25195. doi: 10.1002/jia2.25195.","Lancaster KE","J Int AIDS Soc","2018","2018/10/24","PMC6198168","","10.1002/jia2.25195"
"19552593","In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine","Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH.","AIDS Res Hum Retroviruses. 2009 Jul;25(7):673-7. doi: 10.1089/aid.2009.0003.","Church JD","AIDS Res Hum Retroviruses","2009","2009/06/26","PMC2752753","NIHMS140070","10.1089/aid.2009.0003"
"21335592","Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa","White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.","Clin Trials. 2011 Feb;8(1):103-11. doi: 10.1177/1740774510387170.","White R","Clin Trials","2011","2011/02/22","PMC3478774","NIHMS409269","10.1177/1740774510387170"
"25118795","High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis","Matthews LT, Heffron R, Mugo NR, Cohen CR, Hendrix CW, Celum C, Bangsberg DR, Baeten JM; Partners PrEP Study Team.","J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):91-7. doi: 10.1097/QAI.0000000000000246.","Matthews LT","J Acquir Immune Defic Syndr","2014","2014/08/15","PMC4149628","","10.1097/QAI.0000000000000246"
"24784763","HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention","Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C.","J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):340-8. doi: 10.1097/QAI.0000000000000172.","Donnell D","J Acquir Immune Defic Syndr","2014","2014/05/03","PMC4059553","","10.1097/QAI.0000000000000172"
"21943026","HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043)","Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J Jr, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Sweat M, Coates T, Eshleman SH.","BMC Infect Dis. 2011 Sep 24;11:251. doi: 10.1186/1471-2334-11-251.","Piwowar-Manning E","BMC Infect Dis","2011","2011/09/28","PMC3198953","","10.1186/1471-2334-11-251"
"19367173","Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study","Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, O'Cleirigh C, Chesney MA, Coates TJ, Koblin BA, Mayer KH.","J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):340-8. doi: 10.1097/QAI.0b013e3181a24b38.","Mimiaga MJ","J Acquir Immune Defic Syndr","2009","2009/04/16","PMC3292283","NIHMS310289","10.1097/QAI.0b013e3181a24b38"
"22073290","Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection","Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR 3rd, Quinn TC, Donnell D, Eshleman SH.","PLoS One. 2011;6(11):e27211. doi: 10.1371/journal.pone.0027211. Epub 2011 Nov 2.","Cousins MM","PLoS One","2011","2011/11/11","PMC3206918","","10.1371/journal.pone.0027211"
"22174851","Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure","Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, de Bruyn G, Mullins JI, Nakku-Joloba E, Farquhar C, Essex M, Donnell D, Kiarie J, Haynes B, Goldstein D; Partners in Prevention HSV/HIV Transmission Study Team.","PLoS One. 2011;6(12):e28632. doi: 10.1371/journal.pone.0028632. Epub 2011 Dec 12.","Lingappa JR","PLoS One","2011","2011/12/17","PMC3236203","","10.1371/journal.pone.0028632"
"25389306","Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples","Kahle EM, Bolton M, Hughes JP, Donnell D, Celum C, Lingappa JR, Ronald A, Cohen CR, de Bruyn G, Fong Y, Katabira E, McElrath MJ, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.","J Infect Dis. 2015 May 1;211(9):1451-60. doi: 10.1093/infdis/jiu621. Epub 2014 Nov 10.","Kahle EM","J Infect Dis","2015","2014/11/13","PMC4447828","","10.1093/infdis/jiu621"
"28963304","Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study","Dorward J, Garrett N, Quame-Amaglo J, Samsunder N, Ngobese H, Ngomane N, Moodley P, Mlisana K, Schaafsma T, Donnell D, Barnabas R, Naidoo K, Abdool Karim S, Celum C, Drain PK.","BMJ Open. 2017 Sep 27;7(9):e017507. doi: 10.1136/bmjopen-2017-017507.","Dorward J","BMJ Open","2017","2017/10/01","PMC5623564","","10.1136/bmjopen-2017-017507"
"25861015","Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061","Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH.","J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):446-52. doi: 10.1097/QAI.0000000000000633.","Chen I","J Acquir Immune Defic Syndr","2015","2015/04/11","PMC4482803","NIHMS676141","10.1097/QAI.0000000000000633"
"22745608","Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples","Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA.","PLoS Med. 2012;9(6):e1001251. doi: 10.1371/journal.pmed.1001251. Epub 2012 Jun 26.","Cohen CR","PLoS Med","2012","2012/06/30","PMC3383741","","10.1371/journal.pmed.1001251"
"22170382","NIMH Project Accept (HPTN 043) HIV/AIDS community mobilization (CM) to promote mobile HIV voluntary counseling and testing (MVCT) in rural communities in Northern Thailand: modifications by experience","Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; Project Accept Study Team.","AIDS Behav. 2012 Jul;16(5):1227-37. doi: 10.1007/s10461-011-0099-4.","Kawichai S","AIDS Behav","2012","2011/12/16","PMC3355230","NIHMS365043","10.1007/s10461-011-0099-4"
"20490908","Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial","Donnell D, Mimiaga MJ, Mayer K, Chesney M, Koblin B, Coates T.","AIDS Behav. 2010 Oct;14(5):1182-9. doi: 10.1007/s10461-010-9712-1.","Donnell D","AIDS Behav","2010","2010/05/22","PMC2944957","","10.1007/s10461-010-9712-1"
"23874597","Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043)","Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Celentano DD, Morin SF, Sweat M, Coates T, Eshleman SH.","PLoS One. 2013 Jul 11;8(7):e68349. doi: 10.1371/journal.pone.0068349. Print 2013.","Laeyendecker O","PLoS One","2013","2013/07/23","PMC3708944","","10.1371/journal.pone.0068349"
"25942457","Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study","Kintu A, Hankinson SE, Balasubramanian R, Ertel K, Tumwesigye E, Bangsberg DR, Haberer JE; Partners Ancillary Adherence Study Team.","J Acquir Immune Defic Syndr. 2015 May 1;69(1):36-43. doi: 10.1097/QAI.0000000000000538.","Kintu A","J Acquir Immune Defic Syndr","2015","2015/05/06","PMC4422183","NIHMS656596","10.1097/QAI.0000000000000538"
"19552592","Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors","Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B, Eshleman SH.","AIDS Res Hum Retroviruses. 2009 Jul;25(7):701-5. doi: 10.1089/aid.2009.0014.","Hudelson SE","AIDS Res Hum Retroviruses","2009","2009/06/26","PMC2746939","NIHMS140080","10.1089/aid.2009.0014"
"21406984","Challenges in the design of HIV prevention trials in the United States","Donnell D, Hughes JP, Fleming TR.","J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2(Suppl 2):S136-40. doi: 10.1097/QAI.0b013e3181fbcb61.","Donnell D","J Acquir Immune Defic Syndr","2010","2011/03/17","PMC3298818","NIHMS350429","10.1097/QAI.0b013e3181fbcb61"
"34843674","Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial","Limbada M, Macleod D, Situmbeko V, Muhau E, Shibwela O, Chiti B, Floyd S, Schaap AJ, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) study team.","Lancet HIV. 2022 Jan;9(1):e13-e23. doi: 10.1016/S2352-3018(21)00242-3. Epub 2021 Nov 26.","Limbada M","Lancet HIV","2022","2021/11/29","PMC8716341","","10.1016/S2352-3018(21)00242-3"
"24442226","A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women","Heffron R, Donnell D, Kiarie J, Rees H, Ngure K, Mugo N, Were E, Celum C, Baeten JM; Partners in Prevention HSVHIV Transmission Study.","J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):231-6. doi: 10.1097/QAI.0000000000000013.","Heffron R","J Acquir Immune Defic Syndr","2014","2014/01/21","PMC3898601","NIHMS542845","10.1097/QAI.0000000000000013"
"24058300","Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa","Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR.","PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511. Epub 2013 Sep 10.","Haberer JE","PLoS Med","2013","2013/09/24","PMC3769210","","10.1371/journal.pmed.1001511"
"23362861","The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users","Latkin C, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D.","Addiction. 2013 May;108(5):934-43. doi: 10.1111/add.12095. Epub 2013 Jan 30.","Latkin C","Addiction","2013","2013/02/01","PMC3628934","NIHMS429980","10.1111/add.12095"
"19070413","The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA","Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, Quan VM, Gandham S, Vongchak T, Perdue T, Celentano DD.","Soc Sci Med. 2009 Feb;68(4):740-8. doi: 10.1016/j.socscimed.2008.11.019. Epub 2008 Dec 13.","Latkin CA","Soc Sci Med","2009","2008/12/17","PMC2724962","NIHMS120731","10.1016/j.socscimed.2008.11.019"
"24454728","HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model","Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, Eaton JW, Hauck K, Smith P, Griffith S, Moore A, Donnell D, Vermund SH, Fidler S, Hayes R, Fraser C; HPTN 071 PopART Study Team.","PLoS One. 2014 Jan 15;9(1):e84511. doi: 10.1371/journal.pone.0084511. eCollection 2014.","Cori A","PLoS One","2014","2014/01/24","PMC3893126","","10.1371/journal.pone.0084511"
"17507467","Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations","Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ.","J Virol. 2007 Aug;81(15):7885-93. doi: 10.1128/JVI.00218-07. Epub 2007 May 16.","Huang W","J Virol","2007","2007/05/18","PMC1951291","","10.1128/JVI.00218-07"
"16511414","Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission","Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L.","AIDS. 2006 Jan 9;20(2):217-22. doi: 10.1097/01.aids.0000198089.93196.84.","Jackson JB","AIDS","2006","2006/03/03","","","10.1097/01.aids.0000198089.93196.84"
"22283149","Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries","Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; Partners in Prevention HSV/HIV Transmission Study Team.","AIDS Res Hum Retroviruses. 2012 Oct;28(10):1177-83. doi: 10.1089/aid.2011.0341.","Laeyendecker O","AIDS Res Hum Retroviruses","2012","2012/01/31","PMC3448109","","10.1089/aid.2011.0341"
"19450038","Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States","Latkin C, Donnell D, Celentano DD, Aramrattna A, Liu TY, Vongchak T, Wiboonnatakul K, Davis-Vogel A, Metzger D.","Health Psychol. 2009 May;28(3):323-9. doi: 10.1037/a0014707.","Latkin C","Health Psychol","2009","2009/05/20","PMC2799116","NIHMS162161","10.1037/a0014707"
"25300863","Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial","Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Coombs RW, Hendrix C, Marzinke MA, Frenkel L, Haberer JE, Bangsberg D, Celum C; Partners PrEP Study Team.","Lancet Infect Dis. 2014 Nov;14(11):1055-1064. doi: 10.1016/S1473-3099(14)70937-5. Epub 2014 Oct 7.","Baeten JM","Lancet Infect Dis","2014","2014/10/11","PMC4252589","NIHMS635147","10.1016/S1473-3099(14)70937-5"
"25442691","Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples","Pintye J, Baeten JM, Manhart LE, Celum C, Ronald A, Mugo N, Mujugira A, Cohen C, Were E, Bukusi E, Kiarie J, Heffron R; Partners PrEP Study Team.","Lancet Glob Health. 2014 Nov;2(11):e664-71. doi: 10.1016/S2214-109X(14)70315-8. Epub 2014 Oct 22.","Pintye J","Lancet Glob Health","2014","2014/12/03","PMC4271270","NIHMS637274","10.1016/S2214-109X(14)70315-8"
"20666583","Analysis of HIV diversity using a high-resolution melting assay","Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH.","AIDS Res Hum Retroviruses. 2010 Aug;26(8):913-8. doi: 10.1089/aid.2009.0259.","Towler WI","AIDS Res Hum Retroviruses","2010","2010/07/30","PMC2920076","","10.1089/aid.2009.0259"
"26361174","Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland","Bock NN, Emerson RC, Reed JB, Nkambule R, Donnell DJ, Bicego GT, Okello V, Philip NM, Ehrenkranz PD, Duong YT, Moore JS, Justman JE.","J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):338-44. doi: 10.1097/QAI.0000000000000846.","Bock NN","J Acquir Immune Defic Syndr","2016","2015/09/12","PMC4752404","NIHMS748515","10.1097/QAI.0000000000000846"
"21546309","Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study","Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, Kawichai S, Chingono A, Khumalo-Sakutukwa G, Gray G, Richter L, Kulich M, Sadowski A, Coates T; Project Accept study team.","Lancet Infect Dis. 2011 Jul;11(7):525-32. doi: 10.1016/S1473-3099(11)70060-3. Epub 2011 May 3.","Sweat M","Lancet Infect Dis","2011","2011/05/07","PMC3156626","NIHMS310094","10.1016/S1473-3099(11)70060-3"
"17502727","Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection","Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, Huang W, Hart S, Jackson B, Coates T, Chesney M, Koblin B.","AIDS. 2007 May 31;21(9):1165-74. doi: 10.1097/QAD.0b013e32810fd72e.","Eshleman SH","AIDS","2007","2007/05/16","","","10.1097/QAD.0b013e32810fd72e"
"19617849","Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda","Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke PM, Jackson JB, Guay LA.","J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):32-9. doi: 10.1097/QAI.0b013e3181afd352.","Mmiro FA","J Acquir Immune Defic Syndr","2009","2009/07/21","PMC2767188","NIHMS150702","10.1097/QAI.0b013e3181afd352"
"18931624","Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand","Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, van Rooyen H, Chingono A, Modiba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ; NIMH Project Accept Study Team.","J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):422-31. doi: 10.1097/QAI.0b013e31818a6cb5.","Khumalo-Sakutukwa G","J Acquir Immune Defic Syndr","2008","2008/10/22","PMC2664736","NIHMS87310","10.1097/QAI.0b013e31818a6cb5"
"23183150","Clinician practices and attitudes regarding early antiretroviral therapy in the United States","Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team.","J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):e65-9. doi: 10.1097/QAI.0b013e31826a184c..","Kurth AE","J Acquir Immune Defic Syndr","2012","2012/11/28","PMC3957230","NIHMS544250","10.1097/QAI.0b013e31826a184c."
"21769039","Mortality among injection drug users in northern Thailand: a prospective cohort study","Quan VM, Aramrattana A, Vongchak T, Latkin C, Donnell D, Liu TY, Wiboonnatakul K, Celentano DD.","J Addict Med. 2010 Dec;4(4):217-22. doi: 10.1097/ADM.0b013e3181c78bf4.","Quan VM","J Addict Med","2010","2011/07/20","","","10.1097/ADM.0b013e3181c78bf4"
"18444795","HIV-1 tropism and survival in vertically infected Ugandan infants","Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH.","J Infect Dis. 2008 May 15;197(10):1382-8. doi: 10.1086/587492.","Church JD","J Infect Dis","2008","2008/05/01","","","10.1086/587492"
"28964756","Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial","Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K; HPTN 071 (PopART) Study Team.","Lancet Glob Health. 2017 Nov;5(11):e1133-e1141. doi: 10.1016/S2214-109X(17)30367-4. Epub 2017 Sep 27.","Thomas R","Lancet Glob Health","2017","2017/10/02","PMC5640509","","10.1016/S2214-109X(17)30367-4"
"17885298","Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine","Flys TS, Mwatha A, Guay LA, Nakabiito C, Donnell D, Musoke P, Mmiro F, Jackson JB, Eshleman SH.","AIDS. 2007 Oct 1;21(15):2077-82. doi: 10.1097/QAD.0b013e3282703847.","Flys TS","AIDS","2007","2007/09/22","","","10.1097/QAD.0b013e3282703847"
"28464041","A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial","Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.","PLoS Med. 2017 May 2;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. eCollection 2017 May.","Hayes R","PLoS Med","2017","2017/05/03","PMC5412988","","10.1371/journal.pmed.1002292"
"17262714","Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission","Flys TS, Donnell D, Mwatha A, Nakabiito C, Musoke P, Mmiro F, Jackson JB, Guay LA, Eshleman SH.","J Infect Dis. 2007 Mar 1;195(5):711-5. doi: 10.1086/511433. Epub 2007 Jan 18.","Flys TS","J Infect Dis","2007","2007/01/31","","","10.1086/511433"
"24798765","Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships","Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, Bukusi EA, Tumwesigye E, Baeten JM; Partners PrEP Study Team.","J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):436-42. doi: 10.1097/QAI.0000000000000192.","Mujugira A","J Acquir Immune Defic Syndr","2014","2014/05/07","PMC4077929","NIHMS588467","10.1097/QAI.0000000000000192"
"20949006","Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay","Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH.","PLoS One. 2010 Oct 11;5(10):e13259. doi: 10.1371/journal.pone.0013259.","Laeyendecker O","PLoS One","2010","2010/10/16","PMC2952593","","10.1371/journal.pone.0013259"
"23178437","Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay","Cousins MM, Donnell D, Eshleman SH.","J Mol Diagn. 2013 Jan;15(1):130-7. doi: 10.1016/j.jmoldx.2012.08.008. Epub 2012 Nov 22.","Cousins MM","J Mol Diagn","2013","2012/11/27","PMC3532711","","10.1016/j.jmoldx.2012.08.008"
"31204114","HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.","Lancet. 2019 Jul 27;394(10195):303-313. doi: 10.1016/S0140-6736(19)31288-7. Epub 2019 Jun 13.","Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium","Lancet","2019","2019/06/18","PMC6675739","","10.1016/S0140-6736(19)31288-7"
"18845954","HIV risk behaviors in sub-Saharan Africa and Northern Thailand: baseline behavioral data from Project Accept","Genberg BL, Kulich M, Kawichai S, Modiba P, Chingono A, Kilonzo GP, Richter L, Pettifor A, Sweat M, Celentano DD; NIMH Project Accept Study Team (HPTN 043).","J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):309-19. doi: 10.1097/QAI.0b013e3181893ed0.","Genberg BL","J Acquir Immune Defic Syndr","2008","2008/10/11","PMC2643066","NIHMS87309","10.1097/QAI.0b013e3181893ed0"
"26247080","Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs","Sugarman J, Stalter R, Bokoch K, Liu TY, Donnell D.","IRB. 2015 Jan-Feb;37(1):17-9.","Sugarman J","IRB","2015","2015/08/07","PMC4591048","NIHMS725751",""
"25569838","High incidence is not high exposure: what proportion of prevention trial participants are exposed to HIV?","Dimitrov D, Donnell D, Brown ER.","PLoS One. 2015 Jan 8;10(1):e0115528. doi: 10.1371/journal.pone.0115528. eCollection 2015.","Dimitrov D","PLoS One","2015","2015/01/09","PMC4287619","","10.1371/journal.pone.0115528"
